Advising cancer patients on natural health products - A stuctured approach

Annals of Pharmacotherapy

Volumn 38, Issue 9, 2004, Pages 1406-1411

  De Lemos, Mario L ^a   John, Leela ^a,b   Nakashima, Lynne ^a   O'Brien, Robin K ^a,c   Taylor, Suzanne C M ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Pharmacotherapy Consulting Group   (Canada)

Author keywords

Cancer; Complementary therapies; Counseling; Evidence based medicine; Patient education

Indexed keywords

ALKYLATING AGENT; ALPHA TOCOPHEROL; ANDROGEN; ANTHRACYCLINE DERIVATIVE; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DACARBAZINE; FISH OIL; GINSENG EXTRACT; MELATONIN; MELPHALAN; MITOMYCIN; NATURAL PRODUCT; NITROSOUREA DERIVATIVE; RETINOL; SELENIUM; UBIDECARENONE; ZINC;

ARTICLE; CANADA; CANCER PATIENT; CANCER THERAPY; CASE REPORT; CLINICAL PHARMACY; CONTROLLED STUDY; EVALUATION; EVIDENCE BASED MEDICINE; HUMAN; INFORMATION PROCESSING; OUTCOMES RESEARCH; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TOXICITY TESTING;

BIOLOGICAL FACTORS; DIRECTIVE COUNSELING; DRUG INTERACTIONS; FEMALE; FOCUS GROUPS; HUMANS; MALE; NEOPLASMS; PATIENT CARE; PATIENT EDUCATION; PHARMACISTS; PROFESSIONAL ROLE;

EID: 4143069005     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E062     Document Type: Article

References (25)

1. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000;18:2515-21.
2. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-14.
3. Gulian C, Barnes J, Francis SA. Types and preferred sources of information concerning herbal medicinal products: face-to-face interviews with users of herbal medicinal products (abstract). Int J Pharm Pract 2002;10(suppl): R33.
4. Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998;45:496-500.
5. Gray RE, Greenberg M, Fitch M, Voros P, Chart P, Labrecque M, et al. A strategy for informing patients and health professionals about unconventional cancer therapies. J Cancer Educ 1998;13:31-8.
6. Kaegi E. A patient's guide to choosing unconventional therapies. CMAJ 1998;158:1161-5.
7. Charnock D, Shepperd S, Needham G, Gann R. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health 1999;53:105-11.
8. National Center for Complementary and Alternative Medicine (NCCAM). NCCAM publication no. D156. What is complementary and alternative medicine (CAM)? May 2002. http://nccam.nih.gov/health/whatiscam (accessed 2003 Feb 12).
9. Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997;127:61-9.
10. Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137:889-903.
11. Sandler AD, Brazdziunas D, Cooley WC, Gonzalez de Pijem L, Hirsch D, Kastner TA, et al. Counseling families who choose complementary and alternative medicine for their child with chronic illness or disability. Pediatrics 2001;107:598-601.
12. Dawson S, Manderson L, Tallo VL. A manual for the use of focus group. Boston, MA: International Nutrition Foundation for Developing Countries, 1993.
13. Pohar KJ, Taylor SCM. Ambulatory patient satisfaction with cancer treatment education (abstract). J Oncol Pharm Pract 2000;6:31.
14. Mays N, Pope C. Qualitative research: observational methods in health care settings. BMJ 1995;311:182-4.
15. Alternative Medicine Task Force. Information paper: the role of the pharmacist with respect to complementary/alternative medicine 1999. Ottawa: Canadian Society of Hospital Pharmacists, 2001.
16. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Huntingt) 1999;13:1003-8; discussion 1008, 1011-2.
17. College Council. External policy EP-26: pharmacist distribution of alternative and complementary health products. Vancouver: College of Pharmacists of British Columbia, approved 12 June 1998, revised 2 November 2001.
18. Kaufman DM. ABC of learning and teaching in medicine: applying educational theory in practice. BMJ 2003;326:213-6.
19. Kehoe WA, Katz RC. Health behaviors and pharmacotherapy. Ann Pharmacother 1998;32:1076-86. DOI 10.l345/aph.l7418.
20. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002;94:652-61.
21. Passalacqua R, Campione F, Caminiti C, Salvagni S, Barilli A, Bella M, et al. Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapy. Lancet 1999;353:1310-4. erratum 1999;353:2078.
22. Walker HB. Evaluation of the ability of several herbal resources to answer questions about herbal products asked in drug information centers. Pharmacotherapy 2002;22:1611-5.
23. Mishel MH, Hosteller T, King B, Graham V. Predictors of psychosocial adjustment in patients newly diagnosed with gynecological cancer. Cancer Nurs 1984;7:291-9.
24. Gotay CC, Dumitriu D. Health food store recommendations for breast cancer patients. Arch Fam Med 2000;9:692-9.
25. Calder J, Issenman R, Cawdron R. Health information provided by retail health food outlets. Can J Gastroenterol 2000;14:767-71.